TrialMedical oncology (Northwood, London, England)2015

Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study.

Jing Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.